The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical trial conduct! This comprehensive EDI Framework and Toolkit resource are the products of an expert working group comprised of 3CTN members, trial sponsors, and people with lived experience from underrepresented communities. The resulting materials are available and accessible on the 3CTN website for the benefit of all in the research community. To access, please go to https://3ctn.ca/equity-diversity-and-inclusion-in-clinical-trials/.
CCRA congratulates Canadian researchers on receiving prestigious awards
The CCRA extends its congratulations to members of the Canadian cancer research community for receiving several distinguished awards for biomedical research and scientific excellence in recent days, including:
- John E. Dick, PhD, FRS, FRsC, FAACR, recipient of the Canada Gairdner International Awar... Read More »
The CCRA extends its congratulations to members of the Canadian cancer research community for receiving several distinguished awards for biomedical research and scientific excellence in recent days, including:
- John E. Dick, PhD, FRS, FRsC, FAACR, recipient of the Canada Gairdner International Awar... Read More »
Canadian Strategy for Cancer Control (2019-2029)
The refreshed Canadian Strategy for Cancer Control is here. Based on input from more than 7,500 Canadians including healthcare leaders from across the country, the Strategy sets the course for a more equitable approach to cancer in Canada. No matter who we are or where we live, we should all have access to world-class ... Read More »
The refreshed Canadian Strategy for Cancer Control is here. Based on input from more than 7,500 Canadians including healthcare leaders from across the country, the Strategy sets the course for a more equitable approach to cancer in Canada. No matter who we are or where we live, we should all have access to world-class ... Read More »